Alimera Sciences Inc (ALIM)
3.57
+0.03
(+0.85%)
USD |
NASDAQ |
Apr 23, 16:00
3.56
-0.01
(-0.28%)
After-Hours: 20:00
Alimera Sciences Revenue (TTM): 80.75M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 80.75M |
September 30, 2023 | 68.48M |
June 30, 2023 | 58.71M |
March 31, 2023 | 55.78M |
December 31, 2022 | 54.13M |
September 30, 2022 | 54.06M |
June 30, 2022 | 52.61M |
March 31, 2022 | 59.71M |
December 31, 2021 | 59.03M |
September 30, 2021 | 58.84M |
June 30, 2021 | 59.16M |
March 31, 2021 | 47.50M |
December 31, 2020 | 50.82M |
September 30, 2020 | 54.39M |
June 30, 2020 | 54.77M |
March 31, 2020 | 55.59M |
December 31, 2019 | 53.94M |
September 30, 2019 | 51.71M |
June 30, 2019 | 50.00M |
March 31, 2019 | 49.86M |
Date | Value |
---|---|
December 31, 2018 | 46.60M |
September 30, 2018 | 40.63M |
June 30, 2018 | 39.27M |
March 31, 2018 | 38.92M |
December 31, 2017 | 35.91M |
September 30, 2017 | 37.45M |
June 30, 2017 | 35.96M |
March 31, 2017 | 35.15M |
December 31, 2016 | 34.33M |
September 30, 2016 | 29.48M |
June 30, 2016 | 28.08M |
March 31, 2016 | 24.30M |
December 31, 2015 | 22.44M |
September 30, 2015 | 18.36M |
June 30, 2015 | 13.86M |
March 31, 2015 | 10.28M |
December 31, 2014 | 8.423M |
September 30, 2014 | 7.617M |
June 30, 2014 | 5.967M |
March 31, 2014 | 3.956M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
47.50M
Minimum
Mar 2021
80.75M
Maximum
Dec 2023
56.84M
Average
54.77M
Median
Jun 2020
Revenue (TTM) Benchmarks
Eli Lilly and Co | 34.12B |
NovaBay Pharmaceuticals Inc | 14.73M |
Palatin Technologies Inc | 7.098M |
iBio Inc | -- |
Theriva Biologics Inc | -- |